BioNTech SE/$BNTX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
- Ticker
- $BNTX
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 7,807
- Headquarters
- Mainz, Germany
- Website
- www.biontech.de
BioNTech SE Metrics
BasicAdvanced
$23bn
-
-$7.85
-
-
Price and volume
Market cap
$23bn
52-week high
$124.00
52-week low
$79.52
Average daily volume
898k
Financial strength
Current ratio
7.848
Quick ratio
7.033
Long term debt to equity
1.458
Total debt to equity
1.78
Interest coverage (TTM)
-127.06%
Profitability
EBITDA (TTM)
-1,592.739
Gross margin (TTM)
76.62%
Net profit margin (TTM)
-63.64%
Operating margin (TTM)
-68.57%
Effective tax rate (TTM)
-3.49%
Revenue per employee (TTM)
$392,180
Management effectiveness
Return on assets (TTM)
-5.41%
Return on equity (TTM)
-9.30%
Valuation
Price to revenue (TTM)
7.525
Price to book
1.31
Price to tangible book (TTM)
1.46
Price to free cash flow (TTM)
44.844
Free cash flow yield (TTM)
2.23%
Free cash flow per share (TTM)
2.069
Growth
Revenue change (TTM)
-7.93%
Earnings per share change (TTM)
374.01%
3-year revenue growth (CAGR)
-33.92%
3-year earnings per share growth (CAGR)
-27.80%
What the Analysts think about BioNTech SE
Analyst ratings (Buy, Hold, Sell) for BioNTech SE stock.
BioNTech SE Financial Performance
Revenues and expenses
BioNTech SE Earnings Performance
Company profitability
BioNTech SE News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.